Thematic Session 2 – Regulatory excellence as a driver of innovation: Aligning ecosystem actors (industry, clinics & authorities)

This session will bring together industry leaders, clinicians, academics, and Belgian regulatory authorities (FANC & FAMHP) to explore how regulation can better align with innovation and patient needs.

Key discussion points include:

• How regulatory frameworks influence the development of cutting-edge therapies

• The journey from “first-in-class” innovation to patient access

• The real impact of regulatory pathways across the entire value chain

• Challenges and expectations from both innovators and regulators

• Insights from international practices beyond Belgium and Europe

The session will also feature:

• A practical case study on deploying a clinical trial network in radioligand therapy

• Real-world examples of how collaboration can accelerate access while ensuring compliance

Why attend?

Discover how different stakeholders can work together to create a more agile, innovation-friendly regulatory environment, and identify actionable solutions to bring therapies to patients faster.